Oracea (40mg doxycycline)
Oracea is a once per day 40mg (30mg immediate release and 10mg delayed release) doxycycline treatment for the papules and pustles of rosacea. Galderma promote Oracea as superior to 50mg a day of generic doxycycline because Oracea is a low enough dose to be promoted as an `anti-inflamatory only’ treatment and not suffering from potential problems of higher doses of antibiotics.
Be sure to checkout the Oracea User Reviews.
Recent Rosacea Blog Posts
A study just published in the British Journal of Dermatology has shown that Minocycline 100mg a day is as good, and by some measures is a better treatment for the papules and pustules of rosacea compared to the 40mg a day doxyxcycline treatment Oracea. Minocycline as a treatment for rosacea is relatively unknown, with a lack […]
News today that Dr. Reddy’s subsidiary Promius Pharma has gained tentative approval for their 40mg formulation of doxycycline for the papules and pustles of rosacea. Before we get too excited about the real possibility of the availability of a generic form of Oracea, the announcement tells us that the approval is “subject to an automatic […]
A patent application has emerged that proposed what might be an improvement to the doxycycline based Oracea treatment for rosacea. The patent seeks to create a sub-antibiotic dose formulation of doxycycline that is less susceptible to what it calls the `food effect’. Food effect refers to food-drug interactions which lead to either a decrease or […]
The JAMA Dermatology has just published a summary of the trend in prescription prices from 2009 to 2015. The news is not good. Overall the brand-name prescriptions increased in price FOUR FOLD during this period. Four national chain pharmacies in the West Palm Beach, Florida, area—specifically, Costco, CVS, Sam’s Club, and Walgreens—were initially surveyed in […]
The just published update to the 2011 Cochrane review of interventions for rosacea has given its opinion on the last 4 years of published rosacea research. Previous Cochrane reviews on rosacea interventions have been published in 2004, 2005 and 2011. This review looked at 106 randomized clinical trials with 13,631 participants. Cochrane Review Results The […]